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Interleukin-2 (IL-2) has been implicated as being necessary for the optimal formation of primary CD8 T
cell responses against various pathogens. Here we have examined the role that IL-2 signaling plays in several
aspects of a CD8 T cell response against murine gammaherpesvirus 68 (MHV-68). Exposure to MHV-68
causes a persistent infection, along with infectious mononucleosis, providing a model for studying these
processes in mice. Our study indicates that CD25 is necessary for optimal expansion of the antigen-specific
CD8 T cell response but not for the long-term memory response. Contrastingly, IL-2 signaling through CD25
is absolutely required for CD8 T cell mononucleosis.
Members of the gammaherpesvirus family are associated
with significant diseases, such as nasopharyngeal carcinoma,
lymphoid malignancies, and infectious mononucleosis (16).
Murine gammaherpesvirus 68 (MHV-68) is a 2-herpesvirus
related to the human pathogens Epstein-Barr virus (EBV) and
Kaposi’s sarcoma virus (19, 21). Intranasal (i.n.) infection of
mice with MHV-68 results in acute infection of the lung epi-
thelium, which is eventually controlled; however, the virus also
establishes a latent infection in B cells, dendritic cells, and
macrophages that is maintained throughout the life of the host
(8, 9). Infection with MHV-68 generates a broad array of
antigen-specific CD8 T cells that can control the virus without
eliminating persistent infection (5, 12, 13). Additionally, CD4
T cells and neutralizing antibodies are thought to be critical for
the prevention of virus reactivation (3, 6).
A major complication of EBV infection is infectious mono-
nucleosis (16), which occurs when infection is delayed until
puberty. Signs of disease include dramatic lymph node enlarge-
ment and the presence of large numbers of activated CD8 T
cells in the peripheral blood. Similarly to EBV infection,
MHV-68 induces a polyclonal activation of B cells upon estab-
lishment of latency. Concurrently, a CD8 T cell-dominated
lymphocytosis of the peripheral blood occurs, as seen with
EBV. However, there are distinct differences between the two
types of infectious mononucleosis. CD8 T cell lymphocytosis
seen with EBV consists of a broad array of T cell receptor
specificities, a large proportion of which are specific for EBV
epitopes. In contrast, MHV-68-induced mononucleosis is dom-
inated by oligoclonal V4 CD8 T cells that are not reactive
to MHV-68 epitopes. With MHV-68, the expansion of this
population is dramatic, with levels reaching upwards of 60% of
the peripheral blood CD8 T cell population (20). This occurs
in different mouse strains, across at least five different major
histocompatibility complex (MHC) class I haplotypes. How-
ever, it is important to note that infection of wood mice
(Apodemus sylvaticus) does not induce splenomegaly, as seen
with laboratory strains of mice, indicating a potential lack of
V4 expansion that may be species related (14). Interestingly,
evidence suggests that V4 CD8 T cell expansion does not
require classical MHC class Ia antigen presentation (4). Re-
cent studies instead implicate a secreted viral protein, M1,
capable of stimulating the V4 T cell population in a novel
manner, and the authors propose a role for V4 T cells in
control of MHV-68 infection (7).
We and others have recently shown that IL-2 signaling dur-
ing the early stages of a response to acute viral and bacterial
pathogens is required for optimal expansion and differentia-
tion of CD8 T cells (15, 17, 18). However, reports with other
viruses have shown IL-2-independent primary CD8 T cell
responses (1, 22). Therefore, we wished to determine whether
IL-2 signals are necessary for the expansion, maintenance,
and/or recall of CD8 T cell responses during murine gamma-
herpesvirus infection.
We generated chimeric mice through lethal irradiation of
C57BL/6 mice followed by adoptive transfer of mixed bone
marrow from C57BL/6 wild-type (WT) and CD25/ donors,
as previously described (17). Following previous described proto-
cols, mice were given bone marrow in a 2:1 ratio of CD25//WT
to generate equally proportioned congenic populations in re-
cipient mice (see Fig. S1 in the supplemental material) (1, 17).
The resultant mice contained CD8 T cells of both WT and
CD25/ origin, which could be distinguished by congenic
markers. Chimeric mice were infected intranasally with 400
PFU of MHV-68, and the kinetics of the CD8 T cell response
were followed by antibody and tetramer staining of peripheral
blood for CD8 T cells specific for the epitopes ORF6487 (p56)
and ORF61524 (p79), as previously described (13). While an-
tigen-specific CD25/ CD8 T cells were initially able to
proliferate in response to infection, the peak response was
significantly lower than that of the wild-type cells (Fig. 1A and
B). This indicates that while CD25 is dispensable for early
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activation of CD8 T cells, IL-2 signaling is required for full
expansion of the antigen-specific response to MHV-68. De-
spite this deficit in the acute antiviral response, the resultant
memory populations were not statistically different between
the groups (Fig. 1A and B). In our previous report, CD25/
CD8 T cells were unable to fully differentiate into short-lived
effector cells (SLECs), defined as KLRG1high CD127low (17).
To determine if MHV-68-specific responses were also un-
able to fully differentiate, we infected chimeric mice and
stained p79 CD8 T cells for the cell surface markers
FIG. 1. IL-2 signals are necessary for the optimal expansion of MHV-68-specific CD8 T cells. WT/CD25/ chimeric mice were infected with
MHV-68 intranasally and bled at set time points. The antigen-specific responses against two dominant epitopes, p79 (A) and p56 (B), were
determined via tetramer staining of peripheral blood. p79-specific CD8 T cells from the WT and CD25/ populations were stained at the peak
of the response (day 14 p.i.) for KLRG1 and CD127 to determine their ability to differentiate into short-lived and memory precursor effector cells
(C and D). *, P  0.05; **, P  0.01; ***, P  0.001. Error bars represent standard deviations from the means. Four mice were used per group,
and data are representative of at least two experiments.
FIG. 2. CD25/ CD8 T cells can respond to secondary challenge. WT/CD25/ chimeric mice were infected with MHV-68 i.n. After 60 days,
the percentage of peripheral blood CD8 T cells specific for p79 was determined. Mice were then challenged with rVV p79, and the p79 CD8
population was determined 5 days postchallenge (A). The numbers in the box represent the averages  standard deviations. The average fold
increase was calculated to determine the ability of WT and CD25/ CD8 T cells to respond to a secondary challenge (B). Error bars represent
standard deviations from the means. Four mice were used per group, and data are representative of at least two experiments.
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KLRG1 and CD127. At the peak of the response (14 days
postinfection [p.i.]), p79 WT cells had differentiated into
SLEC (KLRG1high CD127low), memory precursor (MPEC)
(KLRG1low CD127high), and doubly positive populations. How-
ever, the p79 CD25/ cells failed to form the SLEC popu-
lation and instead had a corresponding increase in the MPEC
population, indicating that CD25 is necessary for full effector
differentiation of gammaherpesvirus-specific CD8 T cell re-
sponses (Fig. 1C and D).
To determine whether antigen-specific CD25/ CD8 T
cells were capable of optimally responding to a secondary
challenge, we infected chimeric mice with MHV-68 and waited
60 days before challenging with recombinant vaccinia virus
(rVV) expressing the ORF61524 epitope (2  10
6 PFU, intra-
peritoneal). It is necessary to use a heterologous virus to in-
duce a recall CD8 T cell response since MHV-68 generates a
robust neutralizing antibody response, preventing secondary
infection. Previous studies with rVV indicate that the recall
response of MHV-68-specific CD8 T cells is antigen depen-
dent, since administration of rVV expressing an irrelevant
epitope had no effect upon the MHV-68-specific populations
(2). WT and CD25/ cells were able to respond to the sec-
ondary challenge with similar kinetics (Fig. 2A and B), indi-
cating that MHV-68 memory CD8 T cells are capable of a
generating a recall response in the absence of IL-2 signaling.
These data, together with our previous report (17), show that
the dependence on CD25 for formation of the SLEC popula-
tion is conserved between both persistent and acute virus in-
fections.
WT CD8 T cells underwent a dramatic expansion between
days 15 and 21 p.i. (Fig. 3A), consistent with infectious mono-
nucleosis (10). Interestingly, we did not observe a similar ex-
pansion of CD25/ CD8 T cells, indicating a role for IL-2
signaling in the expansion of CD8 T cells during mononucle-
osis (Fig. 3A). Since mononucleosis is dominated by V4
CD8 T cells, we analyzed these T cells from both naive and
infected mice (17 days p.i.) for expression of CD25 by flow
cytometry. While V4 CD8 T cells from the spleen and
peripheral blood of naive mice did not express detectable lev-
els of CD25, mice infected with MHV-68 expressed interme-
diate levels of CD25 during the time period when dramatic
expansion of V4 T cells occurs (Fig. 3B and C). Consistent
with a role for IL-2 signaling in V4 expansion, we observed a
severe deficit in expansion in the CD25/ population of chi-
meric mice, since the percentage of WT V4 cells increased
dramatically between days 14 and 36 p.i., accompanied by only
a small expansion of the CD25/ V4 population over the
same period (Fig. 4A and B).
During infectious mononucleosis, CD8 T cells are in a
highly activated state and thus express low levels of CD62L
(20). Therefore, we analyzed CD8 T cells from chimeric mice
for expression of CD62L. After MHV-68 infection, the ma-
jority of WT CD8 T cells in the peripheral blood were
CD62Llow, as previously reported (Fig. 4C and D) (20). Inter-
estingly, CD25/ CD8 T cells failed to develop this domi-
nant CD62Llow population, indicating that CD25 is necessary
for the activation of the CD8 T cell compartment in addition
to cell expansion during mononucleosis (Fig. 4C and D). When
we analyzed the V4 CD8 T cell compartment, we observed
that WT cells downregulated expression of CD62L. While
V4 cells from the CD25/ compartment also decreased
expression of CD62L, they did so to a lesser extent both as a
percentage and on a per-cell basis (see Fig. S2 in the supple-
mental material).
In these studies, we have shown that signaling through CD25
is necessary for the generation of an optimal primary CD8 T
cell response against a gammaherpesvirus, since virus-specific
CD8 T cells were unable to expand as robustly as WT cells
and did not fully differentiate into short-lived effector cells.
FIG. 3. V4 CD8 T cells express CD25 upon infection with
MHV-68. WT/CD25/ chimeric mice were infected with MHV-68
i.n., and the percentage of peripheral blood cells that were CD8 was
determined over time for each congenic population (A). V4 CD8
T cells from naive and MHV-68-infected mice (day 17 p.i.) were
analyzed for expression of CD25 (B and C). Isotype control, filled
histogram; naive mice, dashed line; infected mice, solid line (**, P 
0.01). Error bars represent standard deviations from the means. Four
mice were used per group, and data are representative of at least two
experiments.
VOL. 84, 2010 NOTES 10925
These observations are consistent with previous results from
our lab and findings of others using a variety of acute infection
models (17, 18). However, not all persistent infections appear
to require CD25, since the m45-specific response to murine
cytomegalovirus (MCMV) infection occurs normally in the
absence of IL-2 signals (1). What allows for some responses to
be independent of IL-2 remains unknown. Potential explana-
tions could involve differences in tropism, the route of infec-
tion, or the amount of proinflammatory cytokines induced by
each infection. Despite the dependence on CD25 for the short-
term effector response, the memory CD8 T cell response
remained intact in the absence of IL-2 signaling. In contrast,
V4 expansion and mononucleosis never attained normal lev-
els. Unlike the antigen-specific response, which relies upon
peptide/MHC interactions for induction, mononucleosis does
not rely upon conventional antigen presentation (4). Instead,
the M1 protein of MHV-68, expressed during the establish-
ment and expansion of latency in the spleen, appears to drive
V4 expansion (7). Interestingly, our evidence shows that both
antigen-dependent and -independent CD8 T cell expansion
require CD25. Antigen-specific T cells also undergo an apop-
totic contraction phase, followed by a lower frequency of cells
surviving as relatively quiescent memory cells. In contrast, dur-
ing mononucleosis caused by MHV-68, CD8 T cells remain in
an activated state and do not undergo a marked contraction,
providing a potential explanation as to why the WT and
CD25/ V4 populations continue to differ in both number
and phenotype later in the response.
Earlier studies have also identified CD4 T cells as being
critical for the development of MHV-68-induced infectious
mononucleosis (11, 20). We have previously shown that CD4
T cell help was critical for robust expression of CD25 on
activated antigen-specific CD8 T cells. Interestingly, when we
measured CD25 expression on V4 cells from mice lacking
CD4 T cells, we saw a moderate decrease in the level of CD25
expressed (data not shown), indicating one potential reason
why CD4-deficient mice do not experience infectious mono-
nucleosis. However, it is likely that other factors involving
CD4 T cells and activation of B cells are also involved (10).
In conclusion, the significance of these studies is twofold.
First, they shed light on the requirements for MHV-68-in-
duced mononucleosis. Second, our data illustrate that CD25 is
required for both antigen-specific and non-antigen-specific ac-
tivation of CD8 T cell responses, while being dispensable for
memory cell formation. This knowledge may be useful in de-
veloping new T cell-based immune therapies to enhance con-
trol of persistent gammaherpesvirus infections.
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